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1. Introduction 
Met-enkephalin (Tyr-Gly-Gly-Phe-Met) and Leu- 
enkephalin (Tyr-Gly-Gly-Phe-Leu) have recently been 
isolated from procine brain [1] and shown to exhibit 
morphine like activity in different paradigms [1-6].  
For the lack of a direct, sensitive assay, indirect 
methods for the estimation of these morphine like 
peptides have been used [5-7].  These include various 
separation techniques in order to measure peptide 
levels after morphine administration [6]. This paper 
describes the preparation of an immunogenic 
protein-conjugate of Leu-enkephalin and the specificity 
of an antiserum generated to this antigen in rabbits. 
Such an antiserum, when used in a radioimmunoassay 
as described herein, should provide a useful tool for 
studying the role of both Leu- and Met-enkephalin 
in the 'Pain Pathway'. According to a recent 
hypothesis, enkephalin levels in the central nervous 
system should determine not only the pain thres- 
hold but phenomena such as tolerance, physical 
dependence and the withdrawl syndrome as well 
[8,9]. From this respect, the importance of a radio- 
immunoassay is obvious. 
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2. Methods and materials 
2.1. Preparation o f  Leu-enkephalin-BSA conjugate 
Twenty mg (3.3 × 10 -2 mmol) Leu-enkephalin 
(Miles-Yeda Ltd., Rehovot, Israel) and 10 mg bovine 
serum albumin (BSA) (Fraction V, Sigma) were 
dissolved in 0.5 ml water and to them was added 
0.25 ml of freshly prepared solution of 150 mg 
1-e thyl-3 -(3-dimethyl-aminopr yl) carbodiimide 
HCI (Sigma) in water. This mixture was permitted to 
proceed with gentle agitation at room temperature 
for 15 min. The reaction mixture became turbid after 
few minutes [10] and remained so even after 
dilution. The reaction was terminated by dialysis 
against 1 liter of saline for 24 h. The antigen was stored 
in the cold until it was used for immunization. 
2.2. Immunization 
Three mature female rabbits were injected 
intradermaly in several sites along the flank, rump 
and nape with an emulsion of Leu-enkephalin-BSA 
(1 mg/rabbit) in complete Freund's adjuvant. Two 
weeks later they were given a similar immunization 
and after an additional two weeks they were bled 
and the sera were tested for presence of anti-Leu- 
enkephalin antibodies. Subsequently, the rabbits 
were boostered once every month and bled two 
weeks after boosting. 
2.3. Radioimmunoassay (RIA ) o f  Leu-enkephalin 
To 0.1 ml of a known amount of unlabelled Leu- 
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enkephalin or of a heterologous peptide, or rat 
brain extract, in a total volume of 0.3 ml 50 mM 
Tris-HCl buffer (pH 7.0) containing 0.1% 
sodium azide was added 0.1 ml [‘HI Leu-enkephalin 
(50 Ci/mmol) (about 100 pg) in Tris buffer, 
followed by 0.1 ml of antiserum appropriately diluted 
in the same buffer. The dilution of antiserum was 
chosen so as to yield about 40% binding of the 
labelled hapten in the absence of an unlabelled 
peptide. This mixture was incubated for 4 h at 4°C. 
A saturated solution of ammonium sulfate (0.3 ml) was 
then added and the incubation continued for 30 min 
in the cold. The supernatants were discarded by 
aspiration and the precipitates resuspended in 1 ml 
water. Radioactivity was measured in the preciptates 
by sampling 0.9 ml aliquots and counting them 
in a xylene-triton X-100 ‘cocktail’ [ 1 l] in a 
Packard Tri-Carb Spectrometer. 
2.4. Brain extracts 
Five rats of the Charles-River strain (220-260 g) 
were decapitated and their brains were immediately 
removed and homogenized in 5 ml ice cold 5% 
tricliloroacetic acid. After centrifugation at 100 X g 
for 15 min the supernatants were extracted three 
times with 3 ml of benzene, lyophilized and 
reconstituted in 1 ml Tris-HCl buffer. 
3. Results 
3.1. Formation of antibodies to Leu-enkephalin 
Antibodies binding [3 H] Leu-enkephalin 
appeared in the serum of the immunized rabbits 
one month after the first immunization. Three 
months later the serum of one immunized 
rabbit (No. 6) bound 50% of the labelled hapten 
(80 pgjassay tube) at a I:750 dilution; the 
corresponding titers of the sera from the other 
immunized rabbits ranged from 1:200- 1:400. 
3.2. Sensitivity and specificity of the antisentm to 
Leu-enkephalin 
The sensitivity of the RIA for Leu-enkephalin 
was found to be approximately 50 pg (fig. 1). Whole 
brain extracts (from five rats) inhibited the binding of 
[3 H] Leu-enkephalin by the antiserum to Leu- 
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Fig.1. Inhibition of binding of [ ‘H]Leu-enkephalin to antiserum by unlabelled Leuenkephaiin, morphine or by rat brain 
extract. Anti-Leuenkephalin serum used at 1: 500 dilution. 
* Units indicate the dilution of the extract. Original solution contained one brain per 1 ml Tris-buffer. 
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Table 1 
Specificity of anti-Leuenkephalin serum 
No. Compound Relative activity (%) 
1 Tyr-Gly-Gly-Phe-Leu 100.0 
2 Tyr-Gly-Gly-Phe-Met 20.0 
3 Dopa-Gly-Gly-Phe-Met 1.1 
4 Tyr-Gly-Gly-Phe-Leu-NH, 0.3 
5 Arg-Tyr-Gly-Gly-Phe-Met 1.8 
6 Lys-Arg-Tyr-Gly-Gly-Phe-Met 2.2 
7 His-Gly-Gly-Phe-Met 2.7 
8 Tyr-Gly-Gly-Phe-Met-NH, < 0.1 
9 Trp-Gly-Gly-Phe-Met < 0.1 
10 Gly-Gly-Phe-Met << 0.01 
11 Morphine << 0.01 
Peptides and morphine were tested in doses ranging from 
10 pg- 10 mg. Anti Leu-enkephalin was used in a dilution 
of 1:500. Compound No. 1 and 2 were the products of 
Miles-Yeda Ltd., Israel. Compounds No. 3-10 were the 
products of Beckman Instruments Inc., Palo Alto. 
enkephalin-BSA. The inhibition curve was parallel 
to that produced by synthetic Leu-enkephalin 
(fig. 1). Morphine sulfate examined at various 
concentrations did not inhibit [3 H] Leu- 
enkephalin binding. The extent to which the 
antiserum to Leu-enkephalin crossreacted with a 
variety of other analogues to Leu-enkephalin s
shown in table 1. 
4. Discussion 
The physiological function of Leu- and Met- 
enkephalin has not been determined yet. In order 
to facilitate the research in this area there is a need 
for a sensitive, specific and reproducible tool for 
estimating the levels of these peptides in biological 
extracts. The radioimmunoassay reported here offers 
such a procedure. 
The inability of morphine to displace [3H] Leu- 
enkephalin in this assay should simplify the protocols 
used in examining enkephalin levels after narcotics 
administration [6]. Hypotheses described in some 
recent reports [8,9] postulate that the phenomena 
of tolerance, physical dependence and withdrawal 
syndrome are consequences of narcotics - ‘endo 
genous morphine’ interactions. Thus, manipulations of
the enkephalin(s) generating system(s) can now be 
quantitatively examined in order to better understand 
these phenomena s well as the ‘pain pathway’. 
Based on chemical consideration, we decided to The parallel [3H] Leu-enkephalin-binding 
conjugate Leu-enkephalin to BSA by the soluble inhibition curves produced by unlabelled Leu- 
carbodiimide method [IO] although, antigens enkephalin and an extract of rat brain indicate 
generated in this fashion do not show high binding immunochemical similarity if not identity between 
capacity ([ lo,12 and refs. cited therein] ). synthetic Leu-enkephalin and the endogenous 
At a 1: 500 dilution of the antiserum, one can peptides. 
detect he presence of 50 pg Leu-enkephalin per 
assay tube (fig.1). It should be noted that [3H]I_eu- 
enkephalin with a specific activity of 50 Ci/mmol 
is used in this RIA; it should be possible to lower 
the sensitivity limit of this assay by the use of an 
immunoreactive [ 1251] -1abelled peptide. It should 
be noted though, that from the results reported 
here and in a recent report [ 13 ] , it appears that 
substitution on the aromatic ring of Tyr will render 
the peptide inactive. 
Data shown in table 1 illustrate the fact that 
even minute chemical alterations in Leu-enkephalin 
bring about dramatic hanges in the immunoactivity 
of the peptides, as demonstrated by reduced potency 
in the RIA. Met-enkephalin, the more potent of the 
two peptides in different biological tests [ 1,2,5], 
is 5times less active than the homologues antigen 
Leu-enkephalin. Hydroxylation of the tyrosine 
residue, yielding the dopa-analogue of Met-enkephalin 
resulted in a much lower immunoreactivity compared 
to the parent compound (No. 3, 1.1%) while the 
amide derivative of Leu-enkephalin (No. 4) shows a 
marginal activity (0.3%). It is of interest hat both 
the hexa- and hepta-peptides, No. 5 and No. 6, 
which are residues of the c-fragment of lipotropin 
[14] exhibit some activity in displacing antibody- 
bound [3H] Leu-enkephalin. Subsitution of the 
tyrosine residue by histidine (No. 7) shows similar 
reactivity (2.7%). Peptides Nos. 8, 9 and 10, as 
well as morphine, did not demonstrate any 
measurable activity in the concentrations tested. 
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